T

he global pharmaceutical industry was handed a big win on Friday when Canada’s Supreme Court ruled that long-standing criteria for awarding patents are too rigorous, opening the door for drug makers to more easily win patent protection and thwart generic competition.

The decision follows a sustained effort by the industry to force the Canadian government to overhaul its approach to patent law, which it claimed was discriminatory and resulted in more than two dozen pharmaceutical patents being invalided over the last decade.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X